vs
Side-by-side financial comparison of La Rosa Holdings Corp. (LRHC) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
ARS Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($28.1M vs $20.2M, roughly 1.4× La Rosa Holdings Corp.). La Rosa Holdings Corp. runs the higher net margin — -27.4% vs -147.1%, a 119.8% gap on every dollar of revenue. On growth, La Rosa Holdings Corp. posted the faster year-over-year revenue change (3.2% vs -67.6%).
V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
LRHC vs SPRY — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.2M | $28.1M |
| Net Profit | $-5.5M | $-41.3M |
| Gross Margin | 8.4% | — |
| Operating Margin | -24.7% | -147.6% |
| Net Margin | -27.4% | -147.1% |
| Revenue YoY | 3.2% | -67.6% |
| Net Profit YoY | -125.7% | -182.8% |
| EPS (diluted) | $-5.44 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $28.1M | ||
| Q3 25 | $20.2M | $32.5M | ||
| Q2 25 | $23.2M | $15.7M | ||
| Q1 25 | $17.5M | $8.0M | ||
| Q4 24 | $17.7M | $86.6M | ||
| Q3 24 | $19.6M | $2.1M | ||
| Q2 24 | $19.1M | $500.0K | ||
| Q1 24 | $13.1M | $0 |
| Q4 25 | — | $-41.3M | ||
| Q3 25 | $-5.5M | $-51.2M | ||
| Q2 25 | $78.4M | $-44.9M | ||
| Q1 25 | $-95.7M | $-33.9M | ||
| Q4 24 | $-5.1M | $49.9M | ||
| Q3 24 | $-2.5M | $-19.1M | ||
| Q2 24 | $-2.3M | $-12.5M | ||
| Q1 24 | $-4.6M | $-10.3M |
| Q4 25 | — | — | ||
| Q3 25 | 8.4% | — | ||
| Q2 25 | 8.0% | — | ||
| Q1 25 | 8.8% | — | ||
| Q4 24 | 8.9% | — | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 8.9% | — |
| Q4 25 | — | -147.6% | ||
| Q3 25 | -24.7% | -163.7% | ||
| Q2 25 | -10.6% | -302.9% | ||
| Q1 25 | -26.7% | -466.3% | ||
| Q4 24 | -17.1% | 54.5% | ||
| Q3 24 | -8.9% | -1051.6% | ||
| Q2 24 | -9.7% | -3068.0% | ||
| Q1 24 | -35.0% | — |
| Q4 25 | — | -147.1% | ||
| Q3 25 | -27.4% | -157.4% | ||
| Q2 25 | 337.8% | -285.6% | ||
| Q1 25 | -546.5% | -425.7% | ||
| Q4 24 | -28.7% | 57.7% | ||
| Q3 24 | -12.5% | -925.0% | ||
| Q2 24 | -12.2% | -2503.2% | ||
| Q1 24 | -35.1% | — |
| Q4 25 | — | $-0.41 | ||
| Q3 25 | $-5.44 | $-0.52 | ||
| Q2 25 | $15.25 | $-0.46 | ||
| Q1 25 | $-5.86 | $-0.35 | ||
| Q4 24 | $28.54 | $0.52 | ||
| Q3 24 | $-16.49 | $-0.20 | ||
| Q2 24 | $-12.49 | $-0.13 | ||
| Q1 24 | $-0.35 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.0M | $245.0M |
| Total DebtLower is stronger | $642.8K | $96.4M |
| Stockholders' EquityBook value | $1.6M | $114.3M |
| Total Assets | $21.7M | $327.7M |
| Debt / EquityLower = less leverage | 0.41× | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $245.0M | ||
| Q3 25 | $4.0M | $288.2M | ||
| Q2 25 | $5.1M | $240.1M | ||
| Q1 25 | $2.9M | $275.7M | ||
| Q4 24 | $1.4M | $314.0M | ||
| Q3 24 | $1.8M | $204.6M | ||
| Q2 24 | $1.6M | $218.7M | ||
| Q1 24 | $1.1M | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | $642.8K | $96.2M | ||
| Q2 25 | $644.3K | — | ||
| Q1 25 | $645.9K | — | ||
| Q4 24 | $647.6K | $0 | ||
| Q3 24 | $649.2K | — | ||
| Q2 24 | $650.8K | — | ||
| Q1 24 | $652.4K | — |
| Q4 25 | — | $114.3M | ||
| Q3 25 | $1.6M | $147.7M | ||
| Q2 25 | $3.4M | $192.3M | ||
| Q1 25 | $-87.5M | $229.0M | ||
| Q4 24 | $2.6M | $256.8M | ||
| Q3 24 | $5.0M | $201.0M | ||
| Q2 24 | $4.7M | $215.2M | ||
| Q1 24 | $5.6M | $223.9M |
| Q4 25 | — | $327.7M | ||
| Q3 25 | $21.7M | $372.8M | ||
| Q2 25 | $22.9M | $313.5M | ||
| Q1 25 | $21.0M | $327.3M | ||
| Q4 24 | $19.4M | $351.2M | ||
| Q3 24 | $19.7M | $217.6M | ||
| Q2 24 | $18.7M | $222.0M | ||
| Q1 24 | $16.3M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | 0.41× | 0.65× | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.25× | 0.00× | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.12× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.3M | $-43.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-43.5M | ||
| Q3 25 | $-1.3M | $-47.0M | ||
| Q2 25 | $-1.4M | $-39.6M | ||
| Q1 25 | $-3.5M | $-40.7M | ||
| Q4 24 | $-1.1M | $42.0M | ||
| Q3 24 | $-591.6K | $-14.5M | ||
| Q2 24 | $-803.1K | $-7.3M | ||
| Q1 24 | $-538.3K | $-6.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-47.2M | ||
| Q2 25 | — | $-39.6M | ||
| Q1 25 | — | $-40.8M | ||
| Q4 24 | — | $41.7M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | — | $-6.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | -145.4% | ||
| Q2 25 | — | -252.2% | ||
| Q1 25 | — | -512.1% | ||
| Q4 24 | — | 48.2% | ||
| Q3 24 | — | -706.3% | ||
| Q2 24 | — | -1463.4% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LRHC
| Real Estate Residential Brokerage Services | $16.8M | 83% |
| Transferred Over Time | $3.5M | 17% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
